# PlatinumRx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/platinumrx

- Industry: Internet
- Headquarters: Bengaluru, India
- Website: www.platinumrx.in
- Total disclosed funding: $7.6M
- Latest round: Series A (Sep 3, 2025)
- Investors on record: 3

## About

Based in Karnataka, India, and co-founded by Piyush Kumar and Ashutosh Pandey in 2023, Afforis Health Technologies Pvt. Ltd. doing business as PlatinumRx operates as an internet-based company that engages in the online order and doorstep delivery of drugs and medical products. In September 2025, PlatinumRx raised USD 6 million in series A funding led by returning investor Stellaris Venture Partners, with participation from another returning investor India Quotient.

The e-pharmacy company that offers an online or on-call order service for a wide range of healthcare products, including over-the-counter pharmaceuticals, medicines, and equipment under categories like Diabetes, digestive care, heart care, joint and muscle care, kidney and liver care, etc with doorstep delivery anywhere in India. PlatinumRx offers products from a variety of brands such as Copa, Abbott, Ranbaxy, Glemark, Dr. Mrepen, Alkem, etc. Additionally, with its substitution engine, PlatinumRx.in helps consumers find exact substitute medicines with the same salt, strength, and effectiveness at a fraction of the cost. Furthermore, the company provides customer support via phone and WhatsApp to assist with any queries or concerns.

PlatinumRx generates revenue by selling medical and pharma products online through its e-commerce website. Some examples of the products on its website include Montecip FX 10 Tablet at INR 101.2, Thiroace 12.5 mcg tab 100 at INR 82.9, etc.

The company plans to utilize the September 2025 funding to expand operations, increase the number of fulfillment centers, optimize the supply chain, develop robust teams within product and technology departments, and enhance brand visibility.

## Funding rounds

- Series A, Sep 3, 2025, $6M — India Quotient, Stellaris Venture Partners
- Seed, Apr 12, 2024, $0.8M — India Quotient
- Seed, Dec 19, 2023, $0.8M — India Quotient, Stellaris Venture Advisors

## Investors

- India Quotient (https://capitalatlas.ai/funds/india-quotient) — Seed, Series A
- Stellaris Venture Advisors — Seed
- Stellaris Venture Partners (https://capitalatlas.ai/funds/stellaris-venture-partners) — Series A